These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17045425)

  • 1. Structural divergence and adaptive evolution in mammalian cytochromes P450 2C.
    da Fonseca RR; Antunes A; Melo A; Ramos MJ
    Gene; 2007 Jan; 387(1-2):58-66. PubMed ID: 17045425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites.
    Zawaira A; Matimba A; Masimirembwa C
    Pharmacogenet Genomics; 2008 Jun; 18(6):467-76. PubMed ID: 18496126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450.
    Clodfelter KH; Waxman DJ; Vajda S
    Biochemistry; 2006 Aug; 45(31):9393-407. PubMed ID: 16878974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How similar are P450s and what can their differences teach us?
    Graham SE; Peterson JA
    Arch Biochem Biophys; 1999 Sep; 369(1):24-9. PubMed ID: 10462437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].
    Guéguen Y; Mouzat K; Ferrari L; Tissandie E; Lobaccaro JM; Batt AM; Paquet F; Voisin P; Aigueperse J; Gourmelon P; Souidi M
    Ann Biol Clin (Paris); 2006; 64(6):535-48. PubMed ID: 17162257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional evolution and structural conservation in chimeric cytochromes p450: calibrating a structure-guided approach.
    Otey CR; Silberg JJ; Voigt CA; Endelman JB; Bandara G; Arnold FH
    Chem Biol; 2004 Mar; 11(3):309-18. PubMed ID: 15123260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of insect P450.
    Feyereisen R
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1252-5. PubMed ID: 17073796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochromes P450 and drug discovery.
    Lamb DC; Waterman MR; Kelly SL; Guengerich FP
    Curr Opin Biotechnol; 2007 Dec; 18(6):504-12. PubMed ID: 18006294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
    Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
    J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
    Crivori P; Poggesi I
    Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of amino acid residues participated in substrate recognition by cytochrome P450 subfamilies with broad substrate specificity.
    Zharkova MS; Sobolev BN; Yu Oparina N; Veselovsky AV; Archakov AI
    J Mol Recognit; 2013 Feb; 26(2):86-91. PubMed ID: 23334916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-activity relationships (QSARs) within series of inhibitors for mammalian cytochromes P450 (CYPs).
    Lewis DF; Dickins M
    J Enzyme Inhib; 2001 Oct; 16(4):321-30. PubMed ID: 11916137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
    Gillam EM
    Arch Biochem Biophys; 2007 Aug; 464(2):176-86. PubMed ID: 17537393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and structural basis of drift in the functions of closely-related homologous enzyme domains: implications for function annotation based on homology searches and structural genomics.
    Roy A; Srinivasan N; Gowri VS
    In Silico Biol; 2009; 9(1-2):S41-55. PubMed ID: 19537164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of cytochrome P450 evolution].
    Matushkin IuG; Morozova IN; Morozov PS
    Biofizika; 1999; 44(4):624-7. PubMed ID: 10544811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic insight into the unity and diversity of cytochromes P450.
    Lisitsa A; Archakov A; Lewi P; Janssen P
    Methods Find Exp Clin Pharmacol; 2003 Nov; 25(9):733-45. PubMed ID: 14685302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.